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 Over the last quarter of a century machine learning has become one of the most important parts of 
the information technology revolution impacting our lives. Artificial intelligence, the field from which 
machine learning emerged, attempts to make machines that think the way humans think. Machine 
learning is the subfield of artificial intelligence that "gives computers the ability to learn without 
being explicitly programmed", a definition attributed to Arthur Samuel, who applied machine 
learning to play checkers, starting a tradition of using games as a testbed for machine learning 
algorithms.1 
Initially research in artiﬁcial intelligence tackled problems that are intellectually diﬃcult for human 
beings but relatively straightforward for computers, problems which can be addressed by an 
algorithm expressed in rules identified and articulated by the programmer. These could be very 
successful, for example IBM’s Deep Blue defeated Gary Kasparov, the then world chess champion  in 
1996.2 A greater challenge in artiﬁcial intelligence is solving the tasks that are easy for people to 
perform but hard for people to describe, i.e. the ones we solve intuitively, such as understanding 
language or recognising faces.  
In machine learning the computer is programmed to optimize a performance criterion using data 
from past experience, typically a set of example cases with a known classification. We need such 
learning in cases where we cannot directly or easily express how a problem could be solved 
algorithmically but we can identify sets of examples that illustrate the solution.  Such problems can 
be incredibly challenging, as in the example of speech recognition, something that humans perform 
seemingly without difficulty, but without being able to explain how it is done. People of different 
ages and genders or with different accents pronounce the same word differently, indeed the same 
person, having a cold or in a temper, will pronounce a word in a very different way. Huge resources 
were invested into research in speech recognition with relatively little impact until, in around 2009, 
scientists worked out how to take advantage of the huge amounts of processing power and data 
becoming available to build machine learning algorithms capable of tackling these more complex 
problems. This technology, known as deep learning, was rapidly incorporated into speech 
recognition software by Google and, for example, is the reason voice control is a practical way to use 
an android phone. 
Although machine learning dates from the early days of artificial intelligence in the late 1950s it 
underwent a first resurgence when the concept of data mining began to take off about 20 years ago. 
Data mining algorithms look for patterns in information. Machine learning does the same thing, but 
then goes one step further – the program changes its behaviour based on what it learns. 
There are different approaches to machine learning. It is worth noting that statistical approaches 
such as regression that derive an equation from a set of data points are forms of machine learning 
algorithms. Other, less traditional approaches include artificial neural networks which are based on 
an analogy with the operation of the human brain. These are built up from networks of simple 
computational units, neurons, arranged in layers. A particularly powerful approach to building neural 
networks – called deep learning – uses a form of artificial neural network to identify low level 
features in the data, features that can then be used as the basis for a classification learned at higher 
levels of the network. Deep learning is made possible, by cheap hardware to perform large numbers 
of operations in parallel in the form of graphical processing units - chips originally developed for the 
gaming industry, together with huge datasets and open-source software frameworks. It has now 
triggered a second resurgence of interest in machine learning. 
There are many successful applications of machine learning in domains outside of medicine. There 
are commercially available systems for recognizing speech, handwriting and for machine translation. 
Retail companies analyse their past sales data to learn their customers’ behaviour to improve 
customer relations, and many web-based companies use machine learning to power their 
recommendation engines.  Face recognition software is used in airport passport control and the 
development of self-driving cars requires the recognition of a wide variety of possible objects in the 
complex and changing context of the immediate driving environment. But how can developments of 
machine learning impact medicine, and more specifically ophthalmology?  Excitingly, machine 
learning is already here, and is likely to make an even greater impact in many areas of clinical 
ophthalmology and eye research in the near future. 
The most obvious areas for the application of machine learning are in health settings where the data 
to be analysed are complex, but the outcomes are simple and well-defined and the number of 
patients to process is large. Image-based screening programmes are an obvious target.  
Automated retinal image analysis systems (ARIAS) that detect diabetic retinopathy on digital retinal 
images are already in deployment.  Although a number are commercially available3 it is essential to 
have independent validation of how they perform in detecting retinopathy that needs 
ophthalmology opinion, without over-referring those that do not have sight-threatening 
retinopathy.  Independent validation is very important for large scale deployment and this has 
recently been undertaken in a study in the UK on over 100,000 retinal images that have never been 
used to train any ARIAS.  The study by Tufail and coworkers showed that two of the ARIAS tested are 
safe and cost-effective for use in a diabetic screening programme.4,5  Competitions such as Kaggle,6 
where teams compete to try and develop an software that has the best sensitivity and specificity  
are accelerating the interest in the area. Recently scientists at Google Health created a dataset of 
128,000 images and used it to train a deep learning network for diabetic retinopathy .7-9 Although 
the results are very exciting the system is still to be given regulatory approval or have an 
independent assessment on a diverse test as per the UK study.   
Deep learning has been applied in software that analyses optical coherence tomography (OCT) to 
differentiate normal from AMD eyes. The recent publication by Lee and coworkers demonstrated 
high sensitivity and specificity to detect AMD using a big data approach of mining 2.6 million OCT 
images, linking it to EMR data, to finds the tens of thousands of patient’s images required to train 
the algorithm. 10  
Another data rich subspecialty that may benefit from machine learning approaches to is glaucoma, 
where it has been applied to analyse visual fields,11 and identify glaucomatous disc cupping.12   This 
could help screening for glaucoma and to support ophthalmologists assessing the progression of the 
disease in visual fields and disc. 
Machine learning has already been used in the diagnosis of cataract, and improving lens implant 
power selection before cataract surgery using radial based formula13 or support vector machines 14 
but could be applied to other anterior segment areas such as the analysis of corneal topography.  It 
has also been used to develop diagnostic tools for retinopathy of prematurity (ROP).15 Deploying 
these algorithms, for example integrated within camera systems, has great potential to impact 
screening especially in low resource settings.   Given how visual the practice of ophthalmology is, 
and how in many areas diagnosis is made on an image, machine learning could have an impact 
across the specialty.  
With the increasing use of EMR systems, large repositories of both EMR data and images will be 
collected that will allow not just the training of machine learning algorithms but also the 
development of predictive analytics that help model outcomes on an individual level.  As the 
datasets and standardised and enlarge we may be able to apply these techniques to less common 
disorders such as uveitis.16 
Machine learning algorithms, especially deep learning based methods require large amounts of well 
annotated data (“ground truth”) where the annotations are typically generated by expert readers. 
The EMR is a common source of the annotations. However, as reported, the variability and bias of 
expert readings can be challenging for these algorithms and recent publications have argued for the 
need for obtaining readings from multiple raters per image.8 Modelling the user to account for these 
biases and variability can be an important aspect of machine learning.    
We argue that, in parallel with these technical developments, the thinking around the validation of 
emerging machine learning algorithms before clinical deployment, also needs to advance.  
Researchers developing machine learning algorithms generally split the available data into separate 
sets to be used for training, testing and validation. The data may however all be drawn from a single 
site or a narrow range of sites and the results may not generalise to other populations or to all 
imaging devices and protocols. We argue that before clinical deployment is considered, an 
independent study, or one with independent oversight (like clinical drug trials) should be required of 
sufficient size to be confident about detecting clinically important but less common events.  Also 
should learning algorithms be allowed to continue to learn after independent approval when 
exposed to real life data which may alter its performance possibly for the better but in an unchecked 
way? Regulatory authorities will need to adapt to these new challenges. 
The convergence of the availability of large ophthalmology datasets, improvement in machine 
learning algorithms and further improvement in computer processing power has resulted in an 
explosion of interest in machine learning applications for ophthalmology.  But this is not the future, 
the future has already begun. 
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